TEL AVIV, Israel, Feb. 13, 2019 /PRNewswire/ -- MaxQ AI™, a medical diagnostic AI company, today announced that through its collaboration with Intel, it was able to triple the computational performance of its Accipio™ intracranial hemorrhage (ICH) and stroke detection platform, enabling clinicians to prioritize critical patients and provide faster, near real-time ICH diagnosis.